434
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Efficient and Greener Synthesis of Functionalized Isoniazid Azomethines from Aromatic Aldehydes and Isatins Using Citric Acid in Aqueous Ethanol

, , , , ORCID Icon &
Pages 421-433 | Received 22 Jun 2021, Accepted 29 Nov 2021, Published online: 16 Dec 2021

References

  • World Health Organization, “Global tuberculosis report 2020: executive summary.” (2020). https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
  • C. L. Van Halsema, K. L. Fielding, V. N. Chihota, E. C. Russell, J. J. Lewis, G. J. Churchyard, and A. D. Grant, “Tuberculosis Outcomes and Drug Susceptibility in Individuals Exposed to Isoniazid Preventive Therapy in a High HIV Prevalence Setting,” AIDS (London, England) 24, no. 7 (2010): 1051–5.
  • E. Valadas, and F. Antunes, “Tuberculosis, a Re-Emergent Disease,” European Journal of Radiology 55, no. 2 (2005): 154–7.
  • T. H. Manjashetty, P. Yogeeswari, and D. Sriram, “Microwave Assisted One-Pot Synthesis of Highly Potent Novel Isoniazid Analogues,” Bioorganic & Medicinal Chemistry Letters 21, no. 7 (2011): 2125–8.
  • V. Judge, B. Narasimhan, and M. Ahuja, “Isoniazid: The Magic Molecule,” Medicinal Chemistry Research 21, no. 12 (2012): 3940–57.
  • P. E. A. Da Silva, D. F. Ramos, H. G. Bonacorso, I. Agustina, M. R. Oliveira, T. Coelho, J. Navarini, H. R. Morbidoni, N. Zanatta, and M. A. Martins, “Synthesis and in Vitro Antimycobacterial Activity of 3-Substituted 5-Hydroxy-5-Trifluoro[Chloro]methyl-4,5-Dihydro-1H-1-(Isonicotinoyl) Pyrazoles,” International Journal of Antimicrobial Agents 32, no. 2 (2008): 139–44.
  • Michael J. Hearn, Michael H. Cynamon, Michaeline F. Chen, Rebecca Coppins, Jessica Davis, Helen Joo-On Kang, Abigail Noble, Becky Tu-Sekine, Marianne S. Terrot, Daniella Trombino, et al. “Preparation and Antitubercular Activities in Vitro and in Vivo of Novel Schiff Bases of Isoniazid,” European Journal of Medicinal Chemistry 44, no. 10 (2009): 4169–78.
  • D. Sriram, P. Yogeeswari, and K. Madhu, “Synthesis and in Vitro and in Vivo Antimycobacterial Activity of Isonicotinoyl Hydrazones,” Bioorganic & Medicinal Chemistry Letters 15, no. 20 (2005): 4502–5.
  • D. Sriram, P. Yogeeswari, and K. Madhu, “Synthesis and in Vitro Antitubercular Activity of Some 1-[(4-Sub)Phenyl]-3-(4-{1-[(Pyridine-4-Carbonyl)Hydrazono]Ethyl}Phenyl)Thiourea,” Bioorganic & Medicinal Chemistry Letters 16, no. 4 (2006): 876–8.
  • M. J. Hearn, and M. H. Cynamon, “Design and Synthesis of Antituberculars: preparation and Evaluation against Mycobacterium tuberculosis of an Isoniazid Schiff Base,” The Journal of Antimicrobial Chemotherapy 53, no. 2 (2004): 185–91.
  • M. Malhotra, V. Monga, S. Sharma, J. Jain, A. Samad, J. Stables, and A. Deep, “Synthesis, Characterization and Pharmacological Evaluation of (E)-N′-(Substituted-Benzylidene) Isonicotinohydrazide Derivatives as Potent Anticonvulsant Agents,” Medicinal Chemistry Research 21, no. 9 (2012): 2145–52.
  • A. B. Thomas, R. K. Nanda, L. P. Kothapalli, and S. C. Hamane, “Synthesis and Biological Evaluation of Schiff’s Bases and 2-Azetidinones of Isonocotinyl Hydrazone as Potential Antidepressant and Nootropic Agents,” Arabian Journal of Chemistry 9 (2016): S79–S90.
  • R. Kakkar, “Isatin and Its Derivatives: A Survey of Recent Syntheses, Reactions, and Applications,”MedChemComm 10, no. 3 (2019): 351–68.
  • C. R. Prakash, and S. Raja, “Synthesis, Characterization and in Vitro Antimicrobial Activity of Some Novel 5-Substituted Schiff and Mannich Base of Isatin Derivatives,” Journal of Saudi Chemical Society 17, no. 3 (2013): 337–44.
  • S. N. Pandeya, P. Yogeeswari, D. Sriram, E. De Clercq, C. Pannecouque, and M. Witvrouw, “Synthesis and Screening for anti-HIV Activity of Some N-Mannich Bases of Isatin Derivatives,” Chemotherapy 45, no. 3 (1999): 192–6.
  • Z. Xu, S. Zhang, C. Gao, J. Fan, F. Zhao, Z. S. Lv, and L. S. Feng, “Isatin Hybrids and Their anti-Tuberculosis Activity,” Chinese Chemical Letters 28, no. 2 (2017): 159–67. no.
  • A. Somoskovi, L. M. Parsons, and M. Salfinger, “The Molecular Basis of Resistance to Isoniazid, Rifampin, and Pyrazinamide in Mycobacterium tuberculosis,” Respiratory Research 2, no. 3 (2001): 1–5.
  • K. S. Dalal, Y. A. Tayade, Y. B. Wagh, D. R. Trivedi, D. S. Dalal, and B. L. Chaudhari, “Bovine Serum Albumin Catalyzed One-Pot, Three-Component Synthesis of Dihydropyrano [2, 3-c] Pyrazole Derivatives in Aqueous Ethanol,” RSC Advances 6, no. 18 (2016): 14868–79.
  • G. Brahmachari, and B. Banerjee, “Facile and One-Pot Access to Diverse and Densely Functionalized 2-Amino-3-Cyano-4 H-Pyrans and Pyran-Annulated Heterocyclic Scaffolds via an Eco-Friendly Multicomponent Reaction at Room Temperature Using Urea as a Novel Organo-Catalyst,” ACS Sustainable Chemistry & Engineering 2, no. 3 (2014): 411–22.
  • S. A. Padvi, Y. A. Tayade, Y. B. Wagh, and D. S. Dalal, “Bmim] OH: An Efficient Catalyst for the Synthesis of Mono and Bis Spirooxindole Derivatives in Ethanol at Room Temperature,” Chinese Chemical Letters 27, no. 5 (2016): 714–20.[
  • V. N. Mahire, V. E. Patel, and P. P. Mahulikar, “Facile DES-Mediated Synthesis and Antioxidant Potency of Benzimidazoquinazolinone Motifs,”Research on Chemical Intermediates 43, no. 3 (2017): 1847–61.
  • M. M. Khan, S. Khan, and S. C. Sahoo, “Efficient and Eco‐Friendly One‐Pot Synthesis of Functionalized Furan‐2‐One, Pyrrol‐2‐One, and Tetrahydropyridine Using Lemon Juice as a Biodegradable Catalyst,” ChemistrySelect 3, no. 5 (2018): 1371–80.
  • Y. A. Tayade, S. A. Padvi, Y. B. Wagh, and D. S. Dalal, “β-Cyclodextrin as a Supramolecular Catalyst for the Synthesis of Dihydropyrano [2, 3-c] Pyrazole and Spiro [Indoline-3, 4′-Pyrano [2, 3-c] Pyrazole] in Aqueous Medium,”Tetrahedron Letters 56, no. 19 (2015): 2441–7.
  • Hamideh Ahankar, Ali Ramazani, Katarzyna Ślepokura, Tadeusz Lis, and Sang Woo Joo, “Synthesis of Pyrrolidinone Derivatives from Aniline, an Aldehyde and Diethyl Acetylenedicarboxylate in an Ethanolic Citric Acid Solution under Ultrasound Irradiation,” Green Chemistry 18, no. 12 (2016): 3582–93.
  • Z. Madanifar, M. T. Maghsoodlou, M. Kangani, and N. Hazeri, “Citric Acid, a Green Catalyst for the One-Pot, Multi-Component Synthesis of Highly Substituted Piperidines,”Research on Chemical Intermediates 41, no. 12 (2015): 9863–9.
  • N. Seyedi, and H. Khabazzadeh, “Glycerin and Citric Acid: A Green and Efficient Catalytic Medium for Synthesis of Bis (Indolyl) Methanes,” Research on Chemical Intermediates 41, no. 4 (2015): 2603–7.
  • F. Darvish, A. Abdollahzade, and D. Saravani, “Imidazole as an Efficient Catalyst for the Synthesis of 2-Amino-3-Cyano-4H-Chromen-4yl-Phosphonates,” Research on Chemical Intermediates 43, no. 3 (2017): 1487–94.
  • S. Shokrollahi, A. Ramazani, S. J. Tabatabaei Rezaei, A. Mashhadi Malekzadeh, P. Azimzadeh Asiabi, and S. W. Joo, “Citric Acid as an Efficient and Green Catalyst for the Synthesis of Hexabenzylhexaazaisowurtzitane (HBIW),” Iranian Journal of Catalysis 6, no. 1 (2016): 65–8.
  • S. R. Thopate, S. R. Kote, S. V. Rohokale, and N. M. Thorat, “Citric Acid Catalysed Beckmann Rearrangement, under Solvent Free Conditions,” Journal of Chemical Research 35, no. 2 (2011): 124–5.
  • J. Safaei-Ghomi, M. Tavazo, M. R. Vakili, and H. Shahbazi-Alavi, “Chitosan Functionalized by Citric Acid: An Efficient Catalyst for One-Pot Synthesis of 2, 4-Diamino-5 H-[1] Benzopyrano [2, 3-b] Pyridine-3-Carbonitriles 5-(Arylthio) or 5-[(Arylmethyl) Thio] Substituted,”Journal of Sulfur Chemistry 38, no. 3 (2017): 236–48.
  • Y. B. Wagh, S. A. Padvi, P. P. Mahulikar, and D. S. Dalal, “CsF Promoted Rapid Synthesis of Spirooxindole‐Pyran Annulated Heterocycles at Room Temperature in Ethanol,”Journal of Heterocyclic Chemistry 57, no. 3 (2020): 1101–10.
  • Y. B. Wagh, K. C. Tayade, A. Kuwar, S. K. Sahoo, N. Singh, and D. S. Dalal, “Exploration of Highly Selective Fluorogenic ‘on–Off' Chemosensor for H2PO4− Ions: ICT‐Based Sensing and ATPase Activity Profiling,” Luminescence 35, no. 3 (2020): 379–84.
  • D. E. Thurston, D. S. Bose, A. S. Thompson, P. W. Howard, A. Leoni, S. J. Croker, T. C. Jenkins, S. Neidle, J. A. Hartley, and L. H. Hurley, “Synthesis of Sequence-Selective C8-Linked Pyrrolo[2,1-c][1,4]benzodiazepine DNA Interstrand Cross-Linking Agents,” The Journal of Organic Chemistry 61, no. 23 (1996): 8141–7.
  • T. Aboul-Fadl, H. A. Abdel-Aziz, M. K. Abdel-Hamid, T. Elsaman, J. Thanassi, and M. J. Pucci, “Schiff Bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyrase,”Molecules (Basel, Switzerland) 16, no. 9 (2011): 7864–79.
  • K. H. M. E. Tehrani, M. Hashemi, M. Hassan, F. Kobarfard, and S. Mohebbi, “Synthesis and Antibacterial Activity of Schiff Bases of 5-Substituted Isatins,” Chinese Chemical Letters 27, no. 2 (2016): 221–5.
  • T. Aboul-Fadl, F. A. H. Mohammed, and E. A. S. Hassan, “Synthesis, Antitubercular Activity and Pharmacokinetic Studies of Some Schiff Bases Derived from 1-Alkylisatin and Isonicotinic Acid Hydrazide (INH),” Archives of Pharmacal Research 26, no. 10 (2003): 778–84.
  • Y. Z. Zhang, H. Z. Du, H. L. Liu, Q. S. He, Z. Xu, and Z. “Isatin Dimers and Their Biological Activities,”Archiv Der Pharmazie 353, no. 3 (2020): 1900299. no.
  • D. C. A. Navarro, C. A. Sierra, and C. Ochoa-Puentes, “Aqueous Citric Acid as Green Reaction Media for the Synthesis of Octahydroxanthenes,”Revista Colombiana de Química 42, no. 2 (2013): 5–11.
  • D. S. Raghuvanshi, P. P. Mahulikar, and J. S. Meshram, “MFA Zeotype Catalyst: A Greener Approach for the Synthesis of INH Azomethine Scaffolds,” RSC Advances 5, no. 59 (2015): 48071–8.
  • H. Hasan, M. Akhter, W. Akhter, I. Ali, M. Zaheen, I. Ahsan, and D. Mahmood, “Design and Synthesis of Novel N-Substituted-3-Chloro-2-Azetidinone Derivatives as Potential Anticonvulsant Agents,”Medicinal Chemistry Research 20, no. 8 (2011): 1357–63.
  • A. A. Bekhit, A. Hymete, A. Damtew, A. M. I. Mohamed, and A. E. D. A. Bekhit, “Synthesis and Biological Screening of Some Pyridine Derivatives as anti-Malarial Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 27, no. 1 (2012): 69–77.
  • M. T. Shreenivas, B. P. Chetan, and A. R. Bhat, “Synthesis and Pharmacological Evaluation of Certain Schiff Bases and Thiazoldine Derivatives as AT1 angiotension-II (AII) Receptor Antagonists,” Journal of Pharmaceutical Science and Technology 1, no. 2 (2009): 88–94.
  • M. Dabiri, P. Salehi, M. Baghbanzadeh, and M. Bahramnejad, “A Facile Procedure for the One-Pot Synthesis of Unsymmetrical 2, 5-Disubstituted 1, 3, 4-Oxadiazoles,”Tetrahedron Letters 47, no. 39 (2006): 6983–6.
  • P. Ramadevi, R. Singh, A. Prajapati, S. Gupta, and D. Chakraborty, “Cu (II) Complexes of Isoniazid Schiff Bases: DNA/BSA Binding and Cytotoxicity Studies on A549 Cell Line,” Advances in Chemistry 2014 (2014): 1–14.
  • V. S. Rao, and K. V. G. Chandra Sekhar, “Iodobenzene Diacetate Mediated Solid‐State Synthesis of Heterocyclyl‐1, 3, 4‐Oxadiazoles,”Synthetic Communications 34, no. 12 (2004): 2153–7.
  • A. B. Thomas, O. Paradkar, R. K. Nanda, P. N. Tupe, P. A. Sharma, R. Badhe, L. Kothapalli, A. Banerjee, S. Hamane, and A. Deshpande, “Eco-Friendly Synthesis of 2-Azetidinone Analogs of Isonicotinic Acid Hydrazide,”Green Chemistry Letters and Reviews 3, no. 4 (2010): 293–300.
  • A. G. Nerkar, A. K. Saxena, S. A. Ghone, and A. K. Thaker, “In Silico Screening, Synthesis and in Vitro Evaluation of Some Quinazolinone and Pyridine Derivatives as Dihydrofolate Reductase Inhibitors for Anticancer Activity,” E-Journal of Chem 6 (2009) : 97–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.